payors
The Risky Combination of Opioids and Benzos: Payor Strategies for Mitigation
With the concurrent use of benzodiazepines and opioids involved in 16% of fatal overdoses, medication management ...
OCTOBER 21, 2021
Come Together to Increase Biosimilar Uptake
The use of biosimilars could be higher if stakeholders, from manufacturers to payors and pharmacists, united to ...
MAY 27, 2021
ON PAIN: Roadblocks to SCS
Not everyone is a candidate for spinal cord stimulation, and even for those who are, sometimes barriers remain, ...
MARCH 3, 2021
Transparency in Pricing Coming to Health Systems
As of the end of last November, CMS released its final rule requiring hospitals to disclose payor-specific ...
MARCH 11, 2020
Staats ON PAIN: Evidence-Based Medicine
For the final episode of the ON PAIN series with Peter S. Staats, MD, discusses how certain effective pain ...
DECEMBER 6, 2018
Health Care Payors Slow to Implement Policies to Mitigate Opioid Dependence
Health care insurers, including Medicare and Medicaid, are slow to pursue effective policy plans that encourage ...
SEPTEMBER 26, 2018
Did Insurers’ Policies Fuel the Opioid Epidemic?
Insurers’ policies for chronic pain medications are missing important opportunities to steer patients to ...
AUGUST 16, 2018
